Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/16573
Title: First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)
Authors: O'CONNOR, Owen A.OZCAN, MuhitJACOBSEN, Eric D.VIDAL, Josep Maria RonceroTROTMAN, JudithDEMETER, JuditMASSZI, TamasPEREIRA, JulianaRAMCHANDREN, RadhakrishnanD'AMORE, Francesco A.FOSS, FrancineKIM, Won-SeogLEONARD, John P.CHIATTONE, Carlos SergioZINZANI, Pier LuigiLIU, HuaJUNG, JungAhZHOU, XiaofeiLEONARD, E. JaneULLMANN, Claudio DanskySHUSTOV, Andrei R.
Citation: BLOOD, v.126, n.23, 2015
Appears in Collections:

Comunicações em Eventos - FM/MCM
Departamento de Clínica Médica - FM/MCM

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC

Comunicações em Eventos - LIM/31
LIM/31 - Laboratório de Genética e Hematologia Molecular


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.